1Assistant Professor, Symbiosis Institute of Health Sciences, Symbiosis International University, Pune
2Professor and Deputy Director, Symbiosis Institute of Health Sciences, Symbiosis International University, Pune
*Corresponding author: Sammita Jadhav, Professor and Deputy Director, Symbiosis Institute of Health Sciences, Symbiosis International University, Pune. Email Id.: dr_jadhav@sihspune.org
Online published on 19 August, 2019.
The global reach of Japanese Encephalitis Virus (JEV) with an estimated 3 billion people at risk makes this virus a severe threat to the public health. Since its first detection in 1955, this virus has managed to spread throughout the country. Understanding the molecular epidemiology of Japanese Encephalitis Virus in India will help in designing vaccine strategies for preventive initiatives necessary to control the Acute Encephalitis Syndrome (AES) the main implication of the infection caused by the Japanese Encephalitis Virus (JEV).
JEV, AES, Molecular Epidemiology
